Skip to main content

Select Drug Profiles

Mosunetuzumab, a Dual-Targeted Antibody, Shows Complete Remissions in Relapsed/Refractory NHL After CAR T-Cell Therapy

Phoebe Starr

In the Literature, Oncology

Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes

Conference Highlights ASH

Advances in Cellular Therapies for Hematologic Malignancies Highlighted at ASH 2019

Wayne Kuznar

In the Literature, Oncology

Split-Fill Program for Oncology Oral Medications Is Cost-Saving

Nivolumab Monotherapy as Bridge to Transplant in Patients with Relapsed or Refractory Hodgkin Lymphoma

Wayne Kuznar

Practice Management

Real-World Healthcare Utilization and Costs Support Broader Use of CAR T-Cell Therapy

Phoebe Starr

Multiple Myeloma, Oncology

Dual-Targeted CAR T-Cell Therapy Leads to Very High Response Rates in Relapsed or Refractory Multiple Myeloma

Phoebe Starr

Cholangiocarcinoma, Oncology

Surgery for Cholangiocarcinoma

In the Literature, Oncology

Real-World Evidence Supports Patient Navigation in Cancer

Investigational BET Inhibitor, CPI-0610, Promotes Responses in Myelofibrosis

Wayne Kuznar

Page 40 of 244
Results 391 - 400 of 2438